MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

20 May 2022 Evaluate
The revenue zoomed 23.46% to Rs. 287.63 millions for the quarter ended March 2022 as compared to Rs. 232.98 millions during the corresponding quarter last year.Net profit surges 69.05% to Rs. 97.88  millions  from Rs. 57.90 millions in the quarter ended March 2022.The company reported a good operating profit of 145.89 millions compared to 90.99 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 287.63 232.98 23.46 1148.54 905.63 26.82 1148.54 905.63 26.82
Other Income 15.09 7.95 89.81 40.50 32.67 23.97 40.50 32.67 23.97
PBIDT 145.89 90.99 60.34 620.95 435.95 42.44 620.95 435.95 42.44
Interest 1.79 2.93 -38.91 8.28 9.81 -15.60 8.28 9.81 -15.60
PBDT 144.10 88.06 63.64 612.67 426.14 43.77 612.67 426.14 43.77
Depreciation 5.44 6.71 -18.93 22.33 17.32 28.93 22.33 17.32 28.93
PBT 138.66 81.35 70.45 590.34 408.82 44.40 590.34 408.82 44.40
TAX 40.78 23.45 73.90 154.10 107.02 43.99 154.10 107.02 43.99
Deferred Tax 0.62 0.69 -10.14 0.72 1.26 -42.86 0.72 1.26 -42.86
PAT 97.88 57.90 69.05 436.24 301.80 44.55 436.24 301.80 44.55
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 50.72 39.05 29.87 54.06 48.14 12.31 54.06 48.14 12.31
Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..